Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

Anouk W M A Schaeffers, Lot A Devriese, Carla H van Gils, Jan Willem Dankbaar, Jens Voortman, Jan Paul de Boer, Marije Slingerland, Mathijs P Hendriks, Ernst J Smid, Geert W J Frederix, Remco de Bree*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

23 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science